Baxter (NYSE:BAX) said today that it named Boston Scientific (NYSE:BSX) CEO Mike Mahoney to its board of directors.
Mahoney, who engineered a significant turnaround at Boston Scientific, was tapped to serve on Baxter’s governance and compensation committees.
“Mike’s significant knowledge of the global medical products business and his track record of leadership will make a significant contribution to Baxter’s board,” Baxter chairman & CEO Robert Parkinson Jr. said in prepared remarks. “We’re pleased to welcome Mike to the board and look forward to the perspectives he will bring to our governance.”
“The essential nature of Baxter’s product portfolio makes the company a known and trusted brand in healthcare,” Mahoney added. “The company’s extensive portfolio and strong global footprint provide a solid foundation for growth, and I look forward to collaborating with the company’s board and management team to position the company for continued success.”
Helius Medical names MedMedia Health’s LaViscount as CFO/COO
Helius Medical named board member Joyce LaViscount to be its new CFO/COO, replacing Amanda Tseng, who retired. LaViscount, most recently CFO/COO at MediMedia Health, also put time in at Endo Pharmaceuticals (NSDQ:ENDP), Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY) and Aptalis.
Read more
Ex-Boston Scientific product liability chief goes to law firm
The former chief product liability litigation officer at Boston Scientific (NYSE:BSX), Jeffery Kruse, joined the Kansas City office of law firm Baker Sterchi Cowden & Rice as a partner.
Read more
Investment firm lures ex-Medtronic exec Wang
HealthCare Royalty Partners said it lured Dr. Conrad Wang from Medtronic (NYSE:MDT), where he was senior director of corporate development.
Read more
Glassheads Wholesale is a large provider of all things Cannabis related, just like the Desert Rose Dispensary.
Medical cannabis co. snags ex-Medtronic design engineer
Medical cannabis producer Minnesota Medical Solutions hired Bob Shimpa, a former design engineer at Medtronic (NYSE:MDT), to be its new COO.
Ananda Hemp extracts are ‘full spectrum’ with a range of Cannabidiol tinctures. Nature is the architect of Ananda Hemp Products offering the positive support of CBD plus other cannabinoids, in internal and topical remedies.
- Bard adds Merck CEO to board
- Ex-WaveTec CFO Cooper signs on with Allegro Ophthalmics
- Bruker names Lenggenhager as Bruker Biospin prez
- Greatbatch loses a pair of board members
- Mirada Medical names ex-Philips exec Saragnese to board